Update from the soft tissue tumour registry in Jena;Neues aus dem Jenaer Weichteiltumor-Register

Pathologe

Volumn 32, Issue 1, 2011, Pages 40-46

  Petersen, I ^a   Gunther B ^a   Mildner, K ^a   Subhi, F ^a   Knosel T ^a   Altendorf Hofmann, A ^a   Katenkamp, D ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Classification; Epidemiology; Genetics; Molecular diagnostics; Sarcoma, soft tissue

Indexed keywords

DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CLASSIFICATION; CROSS-SECTIONAL STUDY; DNA MICROARRAY; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETICS; GERMANY; HUMAN; MALE; MIDDLE AGED; MOLECULAR DIAGNOSIS; PATHOLOGY; REGISTER; RESEARCH; RETROSPECTIVE STUDY; SARCOMA; SOFT TISSUE TUMOR;

ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CROSS-SECTIONAL STUDIES; DNA PROBES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REGISTRIES; RESEARCH; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 79952445141     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1399-6     Document Type: Article

References (29)

1. Antonescu CR, Yoshida A, Guo T et al (2009) KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res 69:7175-7179
2. Elste AP, Petersen I (2010) Expression of proteinase- activated receptor 1-4 (PAR 1-4) in human cancer. J Mol Histol 41:89-99
3. Filion C, Motoi T, Olshen Ab et al (2009) The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene. J Pathol 217:83-93
4. Fletcher CDM, Unni KK, Mertens F (2002) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon
5. Gajda M, Holzhausen HJ, Oswald S et al (2008) Two cases of retroperitoneal xanthofibrogranuloma suggesting Erdheim-Chester-syndrom. Pathologe 29 (Suppl 1):54
6. Gajda M, Rüdiger KD, Winzer H et al (2010) Liposarcoma of the vagina. Pathologe 31 (Suppl 1):63
7. Kawai A, Woodruff J, Healey JH et al (1998) SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 338:153-160 (Pubitemid 28041862)
8. Knösel T, Heretsch S, Altendorf-Hofmann A et al (2010) TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X 18):analysis of 319 cases. Eur J Cancer 46:1170-1176
9. Knösel T, Katenkamp D, Schulz B, Petersen I (2010) Downregulation of CD34 is associated with malignancy on solitary fibrous tumours- analysis of 279 cases. Pathologe 31 (Suppl 1):17
10. Knösel T, Schulz B, Katenkamp K et al (2010) Solitärer fibröser Tumor und Hämangioperizytom. Was ist neu? Pathologe 31:123-128
11. Kuhn SA, Walter J, Petersen I et al (2010) Cerebral metastasis of a primary heart sarcoma. Neurol Neurochir Pol 44:188-195
12. Ladanyi M, Antonescu CR, Leung DH et al (2002) Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 62:135-140 (Pubitemid 34073997)
13. Lazar A, Abruzzo LV, Pollock RE et al (2006) Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas. Arch Pathol Lab Med 130:1199-1207 (Pubitemid 44168792)
14. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2000) World Health Organization classification of tumours of the central nervous system. IARC, Lyon
15. Nitz C, Petersen I (2010) DNA ploidy and core classification of angiosarcoma. Pathologe 31 (Suppl 1): 45
16. Penzel R, Sers C, Chen Y et al (2011) EGFR mutation detection in NSCLC - assessment of diagnostic application and recommendations of the german panel for mutation testing in NSCLC. Virchows Arch 458: 95-98
17. Petersen I, Schewe C, Pascher A et al (2008) Low grade fibrosarcoma simulating an intraabdominal fibromatosis. Pathologe 29 (Suppl 1):82
18. Riggi N, Cironi L, Suvà ML, Stamenkovic I (2007) Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol 213:4-20 (Pubitemid 47354561)
19. Robert Koch Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V (2010) Krebs in Deutschland 2005/2006. Häufigkeiten und Trends, 7. Aufl. Robert Koch-Institut, Berlin
20. Sahm F, Capper D, Meyer J et al (2010) Immunohistochemical analysis of 1844 human epithelial and hematopoietic tumors and sarcomas for IDH1R132H mutation. Histopathology (im Druck)
21. Schulze S, Petersen I (2010) Gender and ploidy in cancer survival. Cell Oncol (angenommen)
22. Sorensen PH, Lynch JC, Qualman SJ et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 20:2672-2679 (Pubitemid 34575640)
23. Stolz A, Ertych N, Kienitz A et al (2010) The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells. Nat Cell Biol 12:492-499
24. Suvà ML, Cironi L, Riggi N, Stamenkovic I (2007) Sarcomas: genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations. J Pathol 213:117-130 (Pubitemid 47612234)
25. Takenaka S, Ueda T, Naka N et al (2008) Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan. Oncol Rep 19:467-476 (Pubitemid 351176109)
26. Terry J, Saito T, Subramanian S et al (2007) TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol 31:240-246 (Pubitemid 46175025)
27. Travis WD, Brambilla E, Müller Hermelink KH (2004) World Health Organization classification of tumours. Pathology and genetics of tumours oft the lung, pleura, thymus and heart. IARC, Lyon
28. Wardelmann E, Büttner R, Merkelbach-Bruse S, Schildhaus HU (2007) Mutation analysis of gastrointestinal stromal tumors: increasing significance for risk assessment and effective targeted therapy. Virchows Arch 451:743-749 (Pubitemid 47497944)
29. Wölfel C, Liehr T, Weise A, Petersen I (2010) Characterisation of epitheloid haemangioendothelioma with a new Interphase-FISH-Test. Pathologe 31 (Suppl 1):45